Why Is Alzheimer’s Not Just a Brain Disease?
For many years, Alzheimer’s disease was considered solely a neurological issue. Today, however, it is viewed as a reflection of systemic aging. At LaraHealth, we focus not only on the brain but on all bodily systems—from genetic background and mitochondrial function to plasma and gut microbiota.
Dean Ornish Study (2024): Regaining the Brain Through Lifestyle
In a 2024 randomized trial by Dr. Dean Ornish, individuals diagnosed with early-stage Alzheimer’s underwent 20 weeks of intensive lifestyle changes. The protocol included:
- Plant-based nutrition
- Meditation and yoga
- Daily exercise
- Social support and emotional sharing
Results showed:
- Increase in Aβ42/40 ratio (amyloid detoxification)
- Significant improvement in cognitive tests
- Increase in beneficial gut bacteria (Blautia, Eubacterium)
- Greater benefits in those with high adherence (“dose-response” relationship)
At LaraHealth, this protocol is personalized and implemented with the support of functional medicine experts, genetic counselors, life coaches, and neurologists.
AMBAR Study (2020): Detoxifying Neurotoxins Through Plasma Exchange
The AMBAR (Alzheimer Management by Albumin Replacement) study showed that therapeutic plasma exchange (TPE) slowed cognitive decline in Alzheimer’s patients. Key findings included:
- 61% reduction in cognitive decline
- Decrease in Aβ levels after each plasma exchange
- Removal of pro-inflammatory plasma components
At LaraHealth, these effects are supported by IV therapies such as glutathione, NAD+, vitamin C, and ALA, aiming for a “clean internal environment” post-plasma exchange.
HOPE Approach (2025): Systemic Intervention in Aging Biology
Developed by Dr. David Haase, the HOPE (Habitat Optimizing Plasma Exchange) model provides a system-level approach to aging. Scientific findings include:
- “Rejuvenation profile” in gene expression
- Decrease in inflammation and oxidative stress markers
- Rebalancing of the systemic “internal environment”
LaraHealth is built on the principle: “Sustainable healing is not possible without balancing the internal environment.” All supplement plans are personalized based on genetic profiles, microbiota analysis, and biomarkers.
Scientifically Supported Supplements
| Supplement | Scientific Function |
|---|---|
| Omega-3 (DHA/EPA) | Cell membrane health, reduction of neuroinflammation |
| Magnesium L-threonate | Memory, synaptic plasticity |
| B12 + Folate + B6 | Methylation, homocysteine regulation |
| Coenzyme Q10 | Mitochondrial function and energy production |
| Lion’s Mane Mushroom | Neurogenesis, NGF production |
| Glutathione + Vitamin C | Antioxidant defense |
| Psychobiotics | Modulation of the gut-brain axis |
All supplement plans are based on individual genetic profiles, microbiota analysis, and biomarker data.
The LaraHealth Approach: Personalized, Systemic, Science-Based
Our holistic services for Alzheimer’s risk and brain health at LaraHealth include:
- Genetic analysis: APOE, MTHFR, DAO and other risk genes
- IV therapies: NAD+, glutathione, Medivitan, vitamin C
- Neurocognitive testing: Memory, executive functions, attention
- Functional nutrition plans: Elimination diet, anti-inflammatory model
- Sleep, stress, and social bonding coaching: Holistic life optimization
The Role of Neurological Evaluation
Alongside functional and molecular testing, classic neurological assessment forms the foundation of treatment planning. At LaraHealth:
- Multidisciplinary follow-up with neurologists
- Structural analysis via brain MRI
- Objective evaluation of executive functions through psychoneurological tests
- Neuroscience-based approaches in clinical decision-making
Invest in Your Brain, Invest in Your Future
Alzheimer’s is not an inevitable result of aging. With the right interventions, it can be prevented—or even reversed in some cases. At LaraHealth, we offer a systemic and personalized roadmap based on the latest scientific methods. Take action now for your brain.
Frequently Asked Questions
How can I find out if I’m at risk for Alzheimer’s?
Your risk profile can be clearly identified through genetic tests, cognitive screenings, and biomarker analyses.
How often are IV therapies administered?
Frequency is personalized. Typically, sessions are held weekly or biweekly.
Can the Ornish, AMBAR, and HOPE approaches be combined?
Yes. These protocols target different mechanisms and are integrated at LaraHealth.
